Prevalence of Atherogenic Lipoprotein Phenotype among the Obese Medical Students in Bangladesh
Main Article Content
Abstract
Background: Medical students are expected to be conscious about nutrition and healthy active life styles. So, study of obesity & atherogenic lipoproteins among medical students may reflect the prevalence of this cardiovascular risk factor in our population.
Objective: The aim of this study was to assess the prevalence of atherogenic lipoprotein phenotype among the obese medical students in Bangladesh.
Methodology: This descriptive type of Cross-sectional study was carried out at the Department of Biochemistry, Sylhet M.A.G Osmani medical College from july 2018 to June 2019. 100 obese medical students were the study population. Random sampling was done according to availability of the subjects. Data were collected through interviewing of the subjects. The collected data were entered into the computer and analyzed by using SPSS (version 20.1) Result: Majority of the obese subjects (59%) were female. ‘Atherogenic Lipoprotein Phenotype’ components (increased TG, decreased HDL & predominance of small dense LDL) were-- 63%, 54% & 40% respectively. Prevalence of ‘atherogenic lipoprotein phenotype’ was found in 16% in total obese students. In male and female obese students, prevalence of ‘athrorgenic lipoprotein phenotype’ was 14.63% & 16.95% respectively. In male obese students, mean value of TG, HDL & sd LDL (small dense LDL) were-- 177.37, 37.51 and 1.052 respectively. In obese female students, mean value of TG, HDL & sd LDL were-- 163.32, 38.64 and 1.085 respectively. There were no significant differences of any parameter between obese male and female students.
Conclusion: It may be concluded that, our young generation should be aware of atherogenicity due to considerable increased prevalence of obesity & atherogenic lipoprotein phenotype in medical students.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Vidal PM, Bochud M, Mooser V, Paccaud F Wabber G, Voenweider P, 2008. ‘Prevalence of obesity and abdominal obesity in the Lausanne population’. BMC public health, 8: 1-9.
II. Jafar TH, Chaturvedi N and Pappas G. 2006, ‘prevalence of overweight & obesity and their association with hypertension and diabetes mellitus in an Indo-Asians population’ CMAJ, 175(9): 1071-1077.
III. Mohan V and Deep R. 2006, obesity and abdominal obesity is Asian Indians.’ Indian J med res, 123: 593-596.
IV. Djeric M. 2003, pathophysiology & clinical significance of atherogenic lipoprotein phenotype & small dense LDL particles. Jugoslov Med Biohem, 22(2) :101-107.
V. Rizzo M, Berneis K. 2005, ‘lipid triad or atherogenic lipoprotein phenotype: a role in cardiovascular prevention’. Journal atheroscler Thromb, 12(5):237-9.
VI. Arai T, Yamashita S, Hirano K, Sakai N, Kotani K, Fujioka S et al 1994, Increased plasma cholesteryl ester transfer protein in obese subjects. Arterioscler Thromb ,14 :1129-1136
VII. Despres JP, Lemieux I and prudhomne D. 2001, ‘Treatment of obesity; need to focus on high risk abdominally obese patients.’ BMJ, 322:716-20.
VIII. Tchernof A, Lamarche B, Prud’homme D, Nadeau A, Moorjani S, Labrie F et al. 1996, ‘The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity and hyperinsulinemia in men’. Diabetes Care, 19(6): 629-37.
IX. Al-Sultan FA & Al-Zanki N. 2005, Clinical Epidemiology of type 2 Diabetes Mellitus. Kuwait Medical Journal , 37 (2):98-104.
X. Yahia N, Achkar A, Abdallah A, & Rizk S. 2008, ‘Eating habits & obesity among Lebanese University’. Nutr J, 7(32):1-9.
XI. Kang H-S, Gutin B, Barbeau P, Litaker MS, Allison J and Le N-A. 2002, ‘Low density lipoprotein particle size, central obesity, cardiovascular fitness and insulin resistance syndrome markers in obese youths’. International journal of obesity, 26(8): 1030-1035.